AOD-9604
Anti-Obesity Drug 9604
Mechanism of Action
Fragment of HGH (amino acids 176–191) that activates beta-3 adrenergic receptors to stimulate lipolysis without the IGF-1 side effects of full HGH.
Key Benefits
- Targeted fat mobilization without anabolic HGH effects
- No effect on blood glucose or IGF-1 levels
- Cartilage repair evidence in preclinical data
Dosing Protocol
Studied for fat mobilization without anabolic effects. Educational reference only.
Ideal Candidates
Body composition, local fat reduction.
Side Effects & Safety
Generally mild; headache, injection site reactions.
Regulatory Status
RestrictedFDA Category 2 — explicitly on the do-not-compound list.
Frequently asked
What is AOD-9604?+
AOD-9604 (Anti-Obesity Drug 9604) is a peptide studied for targeted fat mobilization and no igf-1 effects. Fragment of HGH (amino acids 176–191) that activates beta-3 adrenergic receptors to stimulate lipolysis without the IGF-1 side effects of full HGH.
What is the dosing protocol for AOD-9604?+
Literature commonly references 300 mcg/day (low) to 500 mcg/day (maintenance) via SubQ daily, on a 12 weeks cycle. Educational reference only — a licensed Stackhaus Health provider sets any personalized protocol.
What is the regulatory status of AOD-9604?+
FDA Category 2 — explicitly on the do-not-compound list.
Where can I access AOD-9604?+
Research-grade AOD-9604 is available through Stackhaus Research. For a personalized, provider-reviewed protocol, consult a licensed clinician through Stackhaus Health.
More in Weight Management
Used in these stacks
AOD-9604 appears in 1 research protocol in the Stackhaus Academy library.